Author

Yi-Jiao Huang

Academy of Military Medical SciencesORCID 0009-0000-7966-9767Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Lin LiiD· 2 shared Lu Lv· 2 shared Qing YeiD· 2 shared Aiping WuiD· 1 shared Bei Sun· 1 shared Cheng‐Feng QiniD· 1 shared Hangyu ZhouiD· 1 shared Hao DuiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Lin LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintMay 21, 2026

Ribophorin-1 Governs Spike Abundance of Highly Pathogenic Coronaviruses by ER-associated degradation

Yi-Jiao Huang, Lu Lv, Wei Ran…·秦成峰

This study identifies Ribophorin-1 as a host factor that reduces spike protein abundance on coronaviruses by promoting its degradation, thereby inhibiting infection.

DOI 10.64898/2026.05.20.726704

mouseproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 14, 2025

Viral protease-Initiated Pyroptosis Activator mRNA therapy as a Universal Antiviral Strategy

Lin Li, Xiuli Yan, Haoyang Wang…·Cheng‐Feng Qin

This paper develops VIPA mRNA therapy, which uses viral protease-initiated pyroptosis to suppress viral replication and elicit immune responses in animal models.

DOI 10.1101/2025.11.14.688189

humanmultiome

𝕏 PostBluesky